The findings showed that it was primarily involved in MAPK signaling pathway, IL-17 signaling pathway, TNF signaling pathway, VEGF signaling pathway, Toll-like receptor signaling pathway and PI3K-Akt signaling pathway, which may be the main targets for hyperuricemia treatment. The gene discussed is IL17A; the disease is hyperuricemia.